Ledger.Open graph →
SEC Form D · filed October 12, 2010

PROTOX THERAPEUTICS INC

Offering
$59.4M
Sold
Exemption
Industry
Biotechnology
Location
Vancouver, British Columbia, Canada
Type

People & firms on this filing (20)

John Parkinson · Vancouver, British Columbia, CanadaExecNina Merchant · Vancouver, British Columbia, CanadaExecFrank Holler · Vancouver, British Columbia, CanadaDirectorFahar Merchant · Vancouver, British Columbia, CanadaExec · DirectorJack Geltosky · Vancouver, British Columbia, CanadaDirectorTom D'Orazio · Vancouver, British Columbia, CanadaExecAlexander Giaquinto · Vancouver, British Columbia, CanadaDirectorJim Heppell · Vancouver, British Columbia, CanadaDirectorJames Miller · Vancouver, British Columbia, CanadaDirectorAvtar Dhillon · Vancouver, British Columbia, CanadaDirectorTimothy F. Etzel · Topeka, KSExec · DirectorMichael F. Mcpherson · Topeka, KSExecJerry F. Mcelroy · Topeka, KSExecDr. Jerry F. Farley · Topeka, KSExecRichard F. Meidinger, M.D · Topeka, KSDirectorDavid S. Fricke · Topeka, KSDirectorLawrence Stubbs · Los Angeles, CADirectorJoshua Phillips · Los Angeles, CADirectorMichael R. Casey · Fort Lauderdale, FLDirectorLou Gallo · Fort Lauderdale, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗